Consumers intrigued by new ReliefChews

WHIPPANY, N.J. — Bayer Healthcare has seen tremendous consumer interest since launching its Alka-Seltzer Heartburn ReliefChews two years ago. IRI data showed that for the 52 weeks ended Aug. 9, sales of the chewable antacid tablets has skyrocketed 520.4% to $16.4 million.

(To view the full Category Review, click here.)



While Alka-Seltzer Heartburn ReliefChews still ranks relatively low on the list of top-selling antacid tablets, the gains made over the last year make the products the category’s fastest-growing brand.



Marketers said ReliefChews — available in assorted-fruit flavor and the recently added cool mint flavor — are soft textured, and do not have a chalky and gritty consistency. In addition, they stressed that ReliefChews provide instant relief of heartburn, neutralizing acid on contact.



In addition to the antacid tablets, Bayer also offers Alka-Seltzer Heartburn + Gas Relief-Chews, providing the added benefit of helping to alleviate such gastrointestinal problems as bloating and pressure.